Vistagen Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
VTGN on Nasdaq
Location
343 Allerton Avenue, South San Francisco, California

There are no Buy or Sell transactions made by insiders since 9/11/2023

Vistagen Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Venrock Healthcare Capital Partners II, L.P. 10%+ Owner $35.4M Jul 12, 2022
H. Ralph Snodgrass Pres./Chief Scientific Officer $170K Dec 31, 2021
Shawn Singh CHIEF EXECUTIVE OFFICER, Director $92.8K Jun 28, 2024
Reid G. Adler Chf Corp Devel Off, Gen Couns $48.8K Jun 28, 2024
Mark Alan Smith Chief Medical Officer $34.2K Jun 30, 2022
Cynthia Anderson Chief Financial Officer $10.6K Jun 28, 2024
Joshua S. Prince Chief Operating Officer $7.9K Jun 28, 2024
Jerrold D. Dotson Vp, Cfo $6.3K Jun 30, 2023
Joanne Curley Director Sep 6, 2024
Jerry B. Gin Director Sep 6, 2024
Ann Michelle Cunningham Director Sep 6, 2024
Margaret M. FitzPatrick Director Sep 6, 2024
Mary L. Rotunno Director Sep 6, 2024
Commodore Capital Lp 10%+ Owner Oct 4, 2023
Jon S. Saxe Director Sep 6, 2024

Recent Insider Transactions by Companies or Individuals for Vistagen Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.